共 50 条
- [42] T-cell immunotherapy with a chimeric receptor against CD38 is effective in eliminating myeloma cells [J]. Leukemia, 2012, 26 : 365 - 367
- [49] Updates in the Classification of T-cell Lymphomas and Lymphoproliferative Disorders [J]. Current Hematologic Malignancy Reports, 2023, 18 : 252 - 263